Tai et al. [53] demonstrated that SINEs including KPT-185 blocked XPO1 with effects similar to shRNA knockdown of XPO1 in multiple myeloma, indicating that specific XPO1 inhibition by KPT-185 mediated anti-tumor properties, rather than an off-target effect. The gene discussed is XPO1; the disease is plasma cell myeloma.